{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,28]],"date-time":"2026-03-28T06:28:26Z","timestamp":1774679306135,"version":"3.50.1"},"reference-count":71,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2026,5,1]],"date-time":"2026-05-01T00:00:00Z","timestamp":1777593600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,5,1]],"date-time":"2026-05-01T00:00:00Z","timestamp":1777593600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,2,16]],"date-time":"2026-02-16T00:00:00Z","timestamp":1771200000000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","ctro.science","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Clinical and Translational Radiation Oncology"],"published-print":{"date-parts":[[2026,5]]},"DOI":"10.1016\/j.ctro.2026.101131","type":"journal-article","created":{"date-parts":[[2026,2,21]],"date-time":"2026-02-21T00:30:20Z","timestamp":1771633820000},"page":"101131","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":0,"special_numbering":"C","title":["ESTRO consensus guidelines on GTV delineation and dose-escalation in rectal cancer"],"prefix":"10.1016","volume":"58","author":[{"given":"Giuditta","family":"Chiloiro","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Angela","family":"Romano","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Regina","family":"Beets-Tan","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Krzysztof","family":"Bujko","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Davide","family":"Cusumano","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Emmanouil","family":"Fokas","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-0364-682X","authenticated-orcid":false,"given":"Karin","family":"Haustermans","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Florence","family":"Huguet","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-5068-5517","authenticated-orcid":false,"given":"Martijn PW","family":"Intven","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Corrie AM","family":"Marijnen","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-8659-131X","authenticated-orcid":false,"given":"Ilaria","family":"Nacci","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Iris D","family":"Nagtegaal","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Femke P","family":"Peters","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-9283-1327","authenticated-orcid":false,"given":"Alexandra","family":"Stewart","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Vincenzo","family":"Valentini","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Maria Antonietta","family":"Gambacorta","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.ctro.2026.101131_b0005","doi-asserted-by":"crossref","first-page":"356","DOI":"10.1016\/S2468-1253(22)00392-2","article-title":"Neoadjuvant chemoradiotherapy with radiation dose escalation with contact x-ray brachytherapy boost or external beam radiotherapy boost for organ preservation in early cT2-cT3 rectal adenocarcinoma (OPERA): a phase 3, randomised controlled trial","volume":"8","author":"Gerard","year":"2023","journal-title":"Lancet Gastroenterol Hepatol"},{"key":"10.1016\/j.ctro.2026.101131_b0010","doi-asserted-by":"crossref","first-page":"102","DOI":"10.1097\/SLA.0000000000002447","article-title":"Organ Preservation in cT2N0 Rectal Cancer after Neoadjuvant Chemoradiation Therapy: the Impact of Radiation Therapy Dose-escalation and consolidation Chemotherapy","volume":"269","author":"Habr-Gama","year":"2019","journal-title":"Ann Surg"},{"key":"10.1016\/j.ctro.2026.101131_b0015","doi-asserted-by":"crossref","first-page":"919","DOI":"10.1016\/S1470-2045(15)00120-5","article-title":"High-dose chemoradiotherapy and watchful waiting for distal rectal cancer: a prospective observational study","volume":"16","author":"Appelt","year":"2015","journal-title":"Lancet Oncol"},{"key":"10.1016\/j.ctro.2026.101131_b0020","doi-asserted-by":"crossref","first-page":"469","DOI":"10.1016\/S0140-6736(17)31056-5","article-title":"Organ preservation for rectal cancer (GRECCAR 2): a prospective, randomised, open-label, multicentre, phase 3 trial","volume":"390","author":"Rullier","year":"2017","journal-title":"Lancet"},{"key":"10.1016\/j.ctro.2026.101131_b0025","doi-asserted-by":"crossref","first-page":"349","DOI":"10.1016\/j.ejso.2019.12.017","article-title":"Role of radiotherapy in the treatment of rectal cancer in older patients","volume":"46","author":"Myint","year":"2020","journal-title":"Eur J Surg Oncol"},{"key":"10.1016\/j.ctro.2026.101131_b0030","doi-asserted-by":"crossref","first-page":"47","DOI":"10.1001\/jamasurg.2018.3752","article-title":"Long-term Oncological and Functional Outcomes of Chemoradiotherapy Followed by Organ-Sparing Transanal Endoscopic Microsurgery for Distal Rectal Cancer: the CARTS Study","volume":"154","author":"Stijns","year":"2019","journal-title":"JAMA Surg"},{"key":"10.1016\/j.ctro.2026.101131_b0035","doi-asserted-by":"crossref","first-page":"92","DOI":"10.1016\/S2468-1253(20)30333-2","article-title":"Radical surgery versus organ preservation via short-course radiotherapy followed by transanal endoscopic microsurgery for early-stage rectal cancer (TREC): a randomised, open-label feasibility study","volume":"6","author":"Bach","year":"2021","journal-title":"Lancet Gastroenterol Hepatol"},{"key":"10.1016\/j.ctro.2026.101131_b0040","doi-asserted-by":"crossref","first-page":"e1","DOI":"10.1016\/j.clon.2020.06.008","article-title":"Neoadjuvant Radiotherapy Dose Escalation in locally Advanced Rectal Cancer: a Systematic Review and Meta-analysis of Modern Treatment Approaches and Outcomes","volume":"33","author":"Hearn","year":"2021","journal-title":"Clin Oncol (R Coll Radiol)"},{"key":"10.1016\/j.ctro.2026.101131_b0045","doi-asserted-by":"crossref","first-page":"9077","DOI":"10.12998\/wjcc.v9.i30.9077","article-title":"Neoadjuvant radiotherapy dose escalation for locally advanced rectal cancers in the new era of radiotherapy: a review of literature","volume":"9","author":"Delishaj","year":"2021","journal-title":"World J Clin Cases"},{"key":"10.1016\/j.ctro.2026.101131_b0050","doi-asserted-by":"crossref","DOI":"10.1016\/j.radonc.2024.110701","article-title":"Analysis of patients with locally advanced rectal cancer given neoadjuvant radiochemotherapy with or without RT dose intensification: a multicenter retrospective study \u2013 ATLANTIS part I","volume":"204","author":"Nicosia","year":"2025","journal-title":"Radiother Oncol"},{"key":"10.1016\/j.ctro.2026.101131_b0055","doi-asserted-by":"crossref","first-page":"29","DOI":"10.1186\/s12880-015-0068-x","article-title":"Metrics for evaluating 3D medical image segmentation: analysis, selection, and tool","volume":"15","author":"Taha","year":"2015","journal-title":"BMC Med Imaging"},{"key":"10.1016\/j.ctro.2026.101131_b0060","doi-asserted-by":"crossref","first-page":"74","DOI":"10.1016\/j.ijrobp.2012.05.017","article-title":"Radiation dose-response model for locally advanced rectal cancer after preoperative chemoradiation therapy","volume":"85","author":"Appelt","year":"2013","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"10.1016\/j.ctro.2026.101131_b0065","doi-asserted-by":"crossref","first-page":"990","DOI":"10.1007\/s11547-020-01189-9","article-title":"A comparative analysis between radiation dose intensification and conventional fractionation in neoadjuvant locally advanced rectal cancer: a monocentric prospective observational study","volume":"125","author":"Bertocchi","year":"2020","journal-title":"Radiol Med"},{"key":"10.1016\/j.ctro.2026.101131_b0070","doi-asserted-by":"crossref","first-page":"139","DOI":"10.1186\/s13014-017-0870-4","article-title":"Preoperative intensity-modulated radiotherapy with a simultaneous integrated boost combined with Capecitabine in locally advanced rectal cancer: short-term results of a multicentric study","volume":"12","author":"Lupattelli","year":"2017","journal-title":"Radiat Oncol"},{"key":"10.1016\/j.ctro.2026.101131_b0075","doi-asserted-by":"crossref","first-page":"70","DOI":"10.1186\/1748-717X-9-70","article-title":"Concomitant boost IMRT-based neoadjuvant chemoradiotherapy for clinical stage II\/III rectal adenocarcinoma: results of a phase II study","volume":"9","author":"Zhu","year":"2014","journal-title":"Radiat Oncol"},{"key":"10.1016\/j.ctro.2026.101131_b0080","doi-asserted-by":"crossref","first-page":"587","DOI":"10.1016\/j.ijrobp.2011.06.2008","article-title":"Four-week neoadjuvant intensity-modulated radiation therapy with concurrent capecitabine and oxaliplatin in locally advanced rectal cancer patients: a validation phase II trial","volume":"83","author":"Arbea","year":"2012","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"10.1016\/j.ctro.2026.101131_b0085","first-page":"8","article-title":"Time to surgery and pathologic complete response after neoadjuvant chemoradiation in rectal cancer: a population study on 2094 patients","volume":"4","author":"Macchia","year":"2017","journal-title":"Clin Transl Radiat Oncol"},{"key":"10.1016\/j.ctro.2026.101131_b0090","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.radonc.2014.08.035","article-title":"Impact of radiotherapy boost on pathological complete response in patients with locally advanced rectal cancer: a systematic review and meta-analysis","volume":"113","author":"Burbach","year":"2014","journal-title":"Radiother Oncol"},{"key":"10.1016\/j.ctro.2026.101131_b0095","doi-asserted-by":"crossref","first-page":"417","DOI":"10.1200\/JCO.22.01296","article-title":"Radio- or Chemotherapy Dose Escalation for Organ Preservation in Rectal Cancer?","volume":"41","author":"Socha","year":"2023","journal-title":"J Clin Oncol"},{"key":"10.1016\/j.ctro.2026.101131_b0100","doi-asserted-by":"crossref","first-page":"897","DOI":"10.1002\/bjs.8732","article-title":"Critical appraisal of the \u201cwait and see\u201d approach in rectal cancer for clinical complete responders after chemoradiation","volume":"99","author":"Glynne-Jones","year":"2012","journal-title":"Br J Surg"},{"key":"10.1016\/j.ctro.2026.101131_b0105","doi-asserted-by":"crossref","first-page":"1109","DOI":"10.1097\/DCR.0b013e3182a25c4e","article-title":"Watch and wait approach following extended neoadjuvant chemoradiation for distal rectal cancer: are we getting closer to anal cancer management?","volume":"56","author":"Habr-Gama","year":"2013","journal-title":"Dis Colon Rectum"},{"key":"10.1016\/j.ctro.2026.101131_b0110","doi-asserted-by":"crossref","first-page":"4218","DOI":"10.3748\/wjg.v26.i29.4218","article-title":"Watch and wait approach in rectal cancer: current controversies and future directions","volume":"26","author":"L\u00f3pez-Campos","year":"2020","journal-title":"World J Gastroenterol"},{"key":"10.1016\/j.ctro.2026.101131_b0115","doi-asserted-by":"crossref","first-page":"807","DOI":"10.1097\/SLA.0b013e3181dae4ed","article-title":"Postoperative complications following surgery for rectal cancer","volume":"251","author":"Paun","year":"2010","journal-title":"Ann Surg"},{"key":"10.1016\/j.ctro.2026.101131_b0120","unstructured":"NCCN guidelines rectal cancer. NCCN n.d. https:\/\/www.nccn.org\/guidelines\/guidelines-detail (accessed June 21, 2022)."},{"key":"10.1016\/j.ctro.2026.101131_b0125","doi-asserted-by":"crossref","unstructured":"Nagtegaal ID, van de Velde CJH, Marijnen CAM, van Krieken JHJM, Quirke P, Dutch Colorectal Cancer Group, et al. Low rectal cancer: a call for a change of approach in abdominoperineal resection. J Clin Oncol 2005;23:9257\u201364. https:\/\/doi.org\/10.1200\/JCO.2005.02.9231.","DOI":"10.1200\/JCO.2005.02.9231"},{"key":"10.1016\/j.ctro.2026.101131_b0130","doi-asserted-by":"crossref","first-page":"74","DOI":"10.1097\/01.sla.0000167926.60908.15","article-title":"The modern abdominoperineal excision: the next challenge after total mesorectal excision","volume":"242","author":"Marr","year":"2005","journal-title":"Ann Surg"},{"key":"10.1016\/j.ctro.2026.101131_b0135","doi-asserted-by":"crossref","first-page":"436","DOI":"10.1016\/j.amjsurg.2017.10.049","article-title":"Outcomes of rectal resection following neoadjuvant therapy in the elderly: can rectal cancer patients be too old for a neoadjuvant approach?","volume":"215","author":"Cirocco","year":"2018","journal-title":"Am J Surg"},{"key":"10.1016\/j.ctro.2026.101131_b0140","doi-asserted-by":"crossref","DOI":"10.1016\/j.ctrv.2022.102490","article-title":"Radiotherapy dose escalation using endorectal brachytherapy in elderly and frail patients with rectal cancer unsuitable for surgery: Lessons from studies in fit patients and future perspectives","volume":"112","author":"Fokas","year":"2023","journal-title":"Cancer Treat Rev"},{"key":"10.1016\/j.ctro.2026.101131_b0145","doi-asserted-by":"crossref","first-page":"363","DOI":"10.21037\/jgo.2017.10.10","article-title":"Management of locally advanced rectal cancer in the elderly: a critical review and algorithm","volume":"9","author":"Hathout","year":"2018","journal-title":"J Gastrointest Oncol"},{"key":"10.1016\/j.ctro.2026.101131_b0150","doi-asserted-by":"crossref","first-page":"358","DOI":"10.1016\/j.ejso.2020.01.005","article-title":"Is watch and wait a safe and effective way to treat rectal cancer in older patients?","volume":"46","author":"Haak","year":"2020","journal-title":"Eur J Surg Oncol"},{"key":"10.1016\/j.ctro.2026.101131_b0155","unstructured":"Karaca S, Aysenur Arli Karacam K. A comparison of dosimetric and clinical parameters between different IMRT boost techniques in preoperative rectal cancer. J BUON 2021;26:1231\u20138."},{"key":"10.1016\/j.ctro.2026.101131_b0160","doi-asserted-by":"crossref","DOI":"10.1016\/j.ijrobp.2020.07.1949","article-title":"Simultaneous Integrated Versus Sequential boost with VMAT in Neoadjuvant Radiotherapy of Rectal Cancer: a Dosimetric Study","volume":"108","author":"Adli","year":"2020","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"10.1016\/j.ctro.2026.101131_b0165","doi-asserted-by":"crossref","first-page":"723","DOI":"10.1080\/0284186X.2017.1400689","article-title":"Tumor volume regression during preoperative chemoradiotherapy for rectal cancer: a prospective observational study with weekly MRI","volume":"57","author":"Van den Begin","year":"2018","journal-title":"Acta Oncol"},{"key":"10.1016\/j.ctro.2026.101131_b0170","doi-asserted-by":"crossref","first-page":"559","DOI":"10.1016\/j.brachy.2019.02.001","article-title":"Optimization of HDRBT boost dose delivery for patients with rectal cancer","volume":"18","author":"Devic","year":"2019","journal-title":"Brachytherapy"},{"key":"10.1016\/j.ctro.2026.101131_b0175","doi-asserted-by":"crossref","first-page":"3665","DOI":"10.3390\/cancers14153665","article-title":"MORPHEUS phase II\u2013III Study: a Pre-Planned Interim Safety Analysis and Preliminary results","volume":"14","author":"Garant","year":"2022","journal-title":"Cancers (Basel)"},{"key":"10.1016\/j.ctro.2026.101131_b0180","doi-asserted-by":"crossref","DOI":"10.1200\/JCO.2022.40.17_suppl.LBA3514","article-title":"Curative chemoradiation for low rectal cancer: Primary clinical outcomes from a multicenter phase II trial","volume":"40","author":"Jensen","year":"2022","journal-title":"JCO"},{"key":"10.1016\/j.ctro.2026.101131_b0185","unstructured":"Vejle Hospital. Randomized Trial of Standard Dose Versus High Dose of Radiotherapy in Rectal Preservation With Chemo-radiotherapy to Patients With Early Low and Mid Rectal Cancer: The Watchful Waiting 3 Trial (WW3). clinicaltrials.gov; 2023."},{"key":"10.1016\/j.ctro.2026.101131_b0190","doi-asserted-by":"crossref","first-page":"163","DOI":"10.1186\/s13014-023-02353-x","article-title":"THeragnostic utilities for neoplastic DisEases of the rectum by MRI guided radiotherapy (THUNDER 2) phase II trial: interim safety analysis","volume":"18","author":"Chiloiro","year":"2023","journal-title":"Radiat Oncol"},{"key":"10.1016\/j.ctro.2026.101131_b0195","doi-asserted-by":"crossref","first-page":"67","DOI":"10.1186\/s12885-021-09158-9","article-title":"THUNDER 2: THeragnostic Utilities for Neoplastic DisEases of the Rectum by MRI guided radiotherapy","volume":"22","author":"Chiloiro","year":"2022","journal-title":"BMC Cancer"},{"key":"10.1016\/j.ctro.2026.101131_b0200","doi-asserted-by":"crossref","first-page":"37","DOI":"10.1016\/j.radonc.2021.09.002","article-title":"A novel approach for radiotherapy dose escalation in rectal cancer using online MR-guidance and rectal ultrasound gel filling - Rationale and first in human","volume":"164","author":"Gani","year":"2021","journal-title":"Radiother Oncol"},{"key":"10.1016\/j.ctro.2026.101131_b0205","doi-asserted-by":"crossref","first-page":"64","DOI":"10.1016\/j.semradonc.2023.10.004","article-title":"Rectal Cancer MRI Guided Radiotherapy: a Practical Review for the physician","volume":"34","author":"Chiloiro","year":"2024","journal-title":"Semin Radiat Oncol"},{"key":"10.1016\/j.ctro.2026.101131_b0210","first-page":"3","article-title":"Protons offer reduced bone marrow, small bowel, and urinary bladder exposure for patients receiving neoadjuvant radiotherapy for resectable rectal cancer","volume":"5","author":"Colaco","year":"2014","journal-title":"J Gastrointest Oncol"},{"key":"10.1016\/j.ctro.2026.101131_b0215","doi-asserted-by":"crossref","DOI":"10.1016\/j.suronc.2021.101638","article-title":"Proton beam therapy in rectal cancer: a systematic review and meta-analysis","volume":"38","author":"Fok","year":"2021","journal-title":"Surg Oncol"},{"key":"10.1016\/j.ctro.2026.101131_b0220","doi-asserted-by":"crossref","first-page":"6285","DOI":"10.2147\/CMAR.S195989","article-title":"Correlation between pelvic bone marrow radiation dose and acute hematological toxicity in cervical cancer patients treated with concurrent chemoradiation","volume":"11","author":"Kumar","year":"2019","journal-title":"Cancer Manag Res"},{"key":"10.1016\/j.ctro.2026.101131_b0225","doi-asserted-by":"crossref","first-page":"235","DOI":"10.1002\/(SICI)1098-2388(200004\/05)18:3<235::AID-SSU7>3.0.CO;2-7","article-title":"Avoiding long-term disturbance to bladder and sexual function in pelvic surgery, particularly with rectal cancer","volume":"18","author":"Havenga","year":"2000","journal-title":"Semin Surg Oncol"},{"key":"10.1016\/j.ctro.2026.101131_b0230","unstructured":"NHS commissioning\u00a0\u00bb Proton beam therapy n.d. https:\/\/www.england.nhs.uk\/commissioning\/spec-services\/highly-spec-services\/pbt\/ (accessed March 17, 2024)."},{"key":"10.1016\/j.ctro.2026.101131_b0235","doi-asserted-by":"crossref","first-page":"1483","DOI":"10.1002\/cncr.29882","article-title":"A systematic review of the cost and cost-effectiveness studies of proton radiotherapy","volume":"122","author":"Verma","year":"2016","journal-title":"Cancer"},{"key":"10.1016\/j.ctro.2026.101131_b0240","doi-asserted-by":"crossref","first-page":"1643","DOI":"10.3390\/cancers14071643","article-title":"The Role of Simultaneous Integrated boost in locally Advanced Rectal Cancer patients with positive Lateral Pelvic Lymph Nodes","volume":"14","author":"Meldolesi","year":"2022","journal-title":"Cancers (Basel)"},{"key":"10.1016\/j.ctro.2026.101131_b0245","doi-asserted-by":"crossref","first-page":"1008","DOI":"10.1016\/j.ijrobp.2020.06.013","article-title":"Efficacy of Dose-Escalated Chemoradiation on complete Tumor Response in patients with locally Advanced Rectal Cancer (RECTAL-BOOST): a phase 2 Randomized Controlled Trial","volume":"108","author":"Couwenberg","year":"2020","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"10.1016\/j.ctro.2026.101131_b0250","doi-asserted-by":"crossref","first-page":"189","DOI":"10.1007\/s12094-016-1522-0","article-title":"Radiation dose intensification in pre-operative chemo-radiotherapy for locally advanced rectal cancer","volume":"19","author":"Alongi","year":"2017","journal-title":"Clin Transl Oncol"},{"key":"10.1016\/j.ctro.2026.101131_b0255","doi-asserted-by":"crossref","first-page":"142","DOI":"10.1016\/j.ijrobp.2011.05.068","article-title":"Phase II study of preoperative helical tomotherapy with a simultaneous integrated boost for rectal cancer","volume":"83","author":"Engels","year":"2012","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"10.1016\/j.ctro.2026.101131_b0260","doi-asserted-by":"crossref","first-page":"104","DOI":"10.1016\/j.ctro.2020.02.001","article-title":"Mesorectal radiotherapy for early stage rectal cancer: a novel target volume","volume":"21","author":"Peters","year":"2020","journal-title":"Clinical and Translational Radiation Oncology"},{"key":"10.1016\/j.ctro.2026.101131_b0265","doi-asserted-by":"crossref","first-page":"110","DOI":"10.1016\/j.radonc.2018.11.023","article-title":"The INTERACT Trial: long-term results of a randomised trial on preoperative capecitabine-based radiochemotherapy intensified by concomitant boost or oxaliplatin, for cT2 (distal)-cT3 rectal cancer","volume":"134","author":"Valentini","year":"2019","journal-title":"Radiother Oncol"},{"key":"10.1016\/j.ctro.2026.101131_b0270","first-page":"206","article-title":"Results of a diagnostic imaging audit in a randomised clinical trial in rectal cancer highlight the importance of careful planning and quality control. Insights","volume":"14","author":"Prata","year":"2023","journal-title":"Imaging"},{"key":"10.1016\/j.ctro.2026.101131_b0275","doi-asserted-by":"crossref","first-page":"1465","DOI":"10.1007\/s00330-017-5026-2","article-title":"Magnetic resonance imaging for clinical management of rectal cancer: Updated recommendations from the 2016 European Society of Gastrointestinal and Abdominal Radiology (ESGAR) consensus meeting","volume":"28","author":"Beets-Tan","year":"2018","journal-title":"Eur Radiol"},{"key":"10.1016\/j.ctro.2026.101131_b0280","first-page":"80","article-title":"Lateral Lymph Nodes in Rectal Cancer: do we all think the same? a Review of Multidisciplinary Obstacles and Treatment Recommendations","volume":"21","author":"Sluckin","year":"2022","journal-title":"Clin Colorectal Cancer"},{"key":"10.1016\/j.ctro.2026.101131_b0285","doi-asserted-by":"crossref","first-page":"2792","DOI":"10.1007\/s00261-023-03893-2","article-title":"Rectal cancer lexicon 2023 revised and updated consensus statement from the Society of Abdominal Radiology Colorectal and Anal Cancer Disease-Focused Panel","volume":"48","author":"Lee","year":"2023","journal-title":"Abdom Radiol (NY)"},{"key":"10.1016\/j.ctro.2026.101131_b0290","doi-asserted-by":"crossref","first-page":"2893","DOI":"10.1007\/s00261-018-1642-9","article-title":"Use of magnetic resonance imaging in rectal cancer patients: Society of Abdominal Radiology (SAR) rectal cancer disease-focused panel (DFP) recommendations 2017","volume":"43","author":"Gollub","year":"2018","journal-title":"Abdom Radiol (NY)"},{"key":"10.1016\/j.ctro.2026.101131_b0295","doi-asserted-by":"crossref","first-page":"219","DOI":"10.1186\/s13014-018-1163-2","article-title":"Delineation of lung cancer with FDG PET\/CT during radiation therapy","volume":"13","author":"Ganem","year":"2018","journal-title":"Radiat Oncol"},{"key":"10.1016\/j.ctro.2026.101131_b0300","doi-asserted-by":"crossref","first-page":"104","DOI":"10.1102\/1470-7330.2007.0013","article-title":"What\u2019s new in target volume definition for radiologists in ICRU Report 71? how can the ICRU volume definitions be integrated in clinical practice?","volume":"7","author":"Berthelsen","year":"2007","journal-title":"Cancer Imaging"},{"key":"10.1016\/j.ctro.2026.101131_b0305","doi-asserted-by":"crossref","first-page":"2599","DOI":"10.3390\/jcm11092599","article-title":"Lymph Nodes Evaluation in Rectal Cancer: where do we stand and Future Perspective","volume":"11","author":"Borgheresi","year":"2022","journal-title":"J Clin Med"},{"key":"10.1016\/j.ctro.2026.101131_b0310","doi-asserted-by":"crossref","first-page":"264","DOI":"10.1097\/COC.0b013e318161dbd3","article-title":"Preoperative capecitabine and accelerated intensity-modulated radiotherapy in locally advanced rectal cancer: a phase II trial","volume":"31","author":"Ballonoff","year":"2008","journal-title":"Am J Clin Oncol"},{"key":"10.1016\/j.ctro.2026.101131_b0315","doi-asserted-by":"crossref","first-page":"570","DOI":"10.1002\/jmri.22696","article-title":"Comparison of diffusion-weighted MRI and MR volumetry in the evaluation of early treatment outcomes after preoperative chemoradiotherapy for locally advanced rectal cancer","volume":"34","author":"Kim","year":"2011","journal-title":"J Magn Reson Imaging"},{"key":"10.1016\/j.ctro.2026.101131_b0320","doi-asserted-by":"crossref","first-page":"863","DOI":"10.1016\/j.ijrobp.2010.12.063","article-title":"Value of diffusion-weighted magnetic resonance imaging for prediction and early assessment of response to neoadjuvant radiochemotherapy in rectal cancer: preliminary results","volume":"82","author":"Lambrecht","year":"2012","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"10.1016\/j.ctro.2026.101131_b0325","doi-asserted-by":"crossref","first-page":"555","DOI":"10.1016\/j.crad.2018.01.007","article-title":"Could early tumour volume changes assessed on morphological MRI predict the response to chemoradiation therapy in locally-advanced rectal cancer?","volume":"73","author":"Palmisano","year":"2018","journal-title":"Clin Radiol"},{"key":"10.1016\/j.ctro.2026.101131_b0330","doi-asserted-by":"crossref","first-page":"564","DOI":"10.1016\/j.radonc.2018.06.019","article-title":"A TCP-based early regression index predicts the pathological response in neo-adjuvant radio-chemotherapy of rectal cancer","volume":"128","author":"Fiorino","year":"2018","journal-title":"Radiother Oncol"},{"key":"10.1016\/j.ctro.2026.101131_b0335","doi-asserted-by":"crossref","first-page":"1007","DOI":"10.1016\/j.annonc.2025.05.528","article-title":"Localised rectal cancer: ESMO Clinical Practice Guideline for diagnosis, treatment and follow-up","volume":"36","author":"Hofheinz","year":"2025","journal-title":"Ann Oncol"},{"key":"10.1016\/j.ctro.2026.101131_b0340","doi-asserted-by":"crossref","first-page":"3114","DOI":"10.7150\/jca.21237","article-title":"A phase II trial of preoperative concurrent chemotherapy and dose escalated intensity modulated radiotherapy (IMRT) for locally advanced rectal cancer","volume":"8","author":"Tey","year":"2017","journal-title":"J Cancer"},{"key":"10.1016\/j.ctro.2026.101131_b0345","doi-asserted-by":"crossref","first-page":"2160","DOI":"10.1111\/codi.16773","article-title":"The safety and efficacy of total mesorectal excision (TME) surgery following dose-escalation: Surgical outcomes from the organ preservation in early rectal adenocarcinoma (OPERA) trial, a European multicentre phase 3 randomised trial (NCT02505750)","volume":"25","author":"Sun Myint","year":"2023","journal-title":"Colorectal Dis"},{"key":"10.1016\/j.ctro.2026.101131_b0350","doi-asserted-by":"crossref","first-page":"272","DOI":"10.1016\/j.canrad.2021.11.002","article-title":"Rectal cancer radiotherapy","volume":"26","author":"Vendrely","year":"2022","journal-title":"Cancer Radiother"},{"key":"10.1016\/j.ctro.2026.101131_b0355","doi-asserted-by":"crossref","first-page":"1057","DOI":"10.1016\/j.ijrobp.2017.12.013","article-title":"American Association of Physicists in Medicine Task Group 263: Standardizing Nomenclatures in Radiation Oncology","volume":"100","author":"Mayo","year":"2018","journal-title":"Int J Radiat Oncol Biol Phys"}],"container-title":["Clinical and Translational Radiation Oncology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2405630826000261?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2405630826000261?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,3,28]],"date-time":"2026-03-28T04:26:49Z","timestamp":1774672009000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2405630826000261"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,5]]},"references-count":71,"alternative-id":["S2405630826000261"],"URL":"https:\/\/doi.org\/10.1016\/j.ctro.2026.101131","relation":{},"ISSN":["2405-6308"],"issn-type":[{"value":"2405-6308","type":"print"}],"subject":[],"published":{"date-parts":[[2026,5]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"ESTRO consensus guidelines on GTV delineation and dose-escalation in rectal cancer","name":"articletitle","label":"Article Title"},{"value":"Clinical and Translational Radiation Oncology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ctro.2026.101131","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"simple-article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 The Authors. Published by Elsevier B.V. on behalf of European Society for Radiotherapy and Oncology.","name":"copyright","label":"Copyright"}],"article-number":"101131"}}